Future tests on atherosclerosis-prone apolipoprotein E-deficient (Apoe−/−) mice are planned to assess the in vivo efficiency of the newly developed PET radiotracers and to investigate their in vivo characteristics. The gene discussed is APOE; the disease is atherosclerosis.